Sterne Kessler Goldstein Fox

Dr. Brian Del Buono's presentation is entitled, "Legislative and regulatory developments impacting the biologics and biosimilars marketplace."  The discussion will cover:

• Update on progress of biosimilars legislation through the U.S. House
  and Senate
• Analysis of the provisions of the competing U.S. bills
• Comparison of the proposed biosimilars legislation to small molecule regulation under Hatch-Waxman
• Views of affected constituencies (biopharma companies, generics companies, health care providers, patients)
• Comparison of the proposed US regulatory scheme to those in other parts of the world (especially Europe and Japan)